SEROTONINERGIC MECHANISMS IN HYPERTENSION - FOCUS ON THE EFFECTS OF KETANSERIN

被引：116

作者：

VANHOUTTE, P

AMERY, A

BIRKENHAGER, W

BRECKENRIDGE, A

BUHLER, F

DISTLER, A

DORMANDY, J

DOYLE, A

FROHLICH, E

HANSSON, L

HEDNER, T

HOLLENBERG, N

JENSEN, HE

LUNDJOHANSEN, P

MEYER, P

OPIE, L

ROBERTSON, I

SAFAR, M

SCHALEKAMP, M

SYMOENS, J

TRAPJENSEN, J

ZANCHETTI, A

机构：

[1] CATHOLIC UNIV LEUVEN,LIEKENHUIS GASTHUISBERG,B-3000 LOUVAIN,BELGIUM

[2] UNIV LIVERPOOL,LIVERPOOL L69 3BX,ENGLAND

[3] FREE UNIV BERLIN,KLINIKUM STEGLITZ,D-1000 BERLIN 45,FED REP GER

[4] ST JAMES HOSP,LONDON SW12 8HW,ENGLAND

[5] UNIV MELBOURNE,DEPT PHYSIOL,PARKVILLE,VIC 3052,AUSTRALIA

[6] ALTON OCHSNER MED FDN & OCHSNER CLIN,NEW ORLEANS,LA 70121

[7] GOTHENBURG UNIV,DEPT CLIN PHARMACOL,S-41124 GOTHENBURG,SWEDEN

[8] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115

[9] HVIDOVRE HOSP,DEPT DIALYSIS,DK-2650 HVIDOVRE,DENMARK

[10] HAUKELAND HOSP,DEPT INTERNAL MED,N-5016 BERGEN,NORWAY

[11] HOP NECKER ENFANTS MALAD,DEPT PHARMACOL,F-75730 PARIS 15,FRANCE

[12] UNIV CAPE TOWN,DEPT MED,CAPE TOWN,SOUTH AFRICA

[13] WESTERN INFIRM,BLOOD PRESSURE UNIT,GLASGOW G11 6NT,SCOTLAND

[14] HOP BROUSSAIS,F-75674 PARIS 14,FRANCE

[15] JANSSEN PHARMACEUT,DEPT CLIN RES,B-2340 BEERSE,BELGIUM

[16] FREDERIKSBERG HOSP,DEPT PHYSIOL,DK-2000 COPENHAGEN,DENMARK

[17] UNIV MILAN,CTR PHYSIOL CLIN & IPERTENS,IST CLIN MED GEN,I-20122 MILAN,ITALY

[18] ZUIDERZIEKENHUIS,DEPT INTERNAL MED,ROTTERDAM,NETHERLANDS

[19] UNIV KLIN BASEL,KANTONSSPITAL,BASEL,SWITZERLAND

[20] OSTRA HOSP,DEPT MED,GOTEBORG,SWEDEN

[21] AKAD ZIEKENHUIS DIJKZIGT,ROTTERDAM,NETHERLANDS

来源：

HYPERTENSION | 1988年 / 11卷 / 02期

关键词：

D O I：

10.1161/01.HYP.11.2.111

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：111 / 133

页数：23

共 325 条

[91]

ERSPAMER V, 1986, J HYPERTENS, V4, pS3

[92]

FAGARD R, 1984, BRIT HEART J, V51, P149

[93] RESPONSES OF THE SYSTEMIC CIRCULATION AND OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM TO KETANSERIN AT REST AND EXERCISE IN NORMAL MAN [J].

FAGARD, R ;

CATTAERT, A ;

LIJNEN, P ;

STAESSEN, J ;

VANHEES, L ;

MOERMAN, E ;

AMERY, A .

CLINICAL SCIENCE, 1984, 66 (01) :17-25

[94]

FALASCHI P, 1986, MODULATION CENTRAL P, P393

[95] TILTING IN HYPERTENSIVE PATIENTS RECEIVING KETANSERIN - RESPONSE [J].

FERRARA, LA ;

PASANISI, F ;

FASANO, ML ;

SORO, S .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (04) :505-506

[96] CARDIOVASCULAR EFFECTS OF KETANSERIN, A NEW ANTISEROTONERGIC AGENT IN THE TREATMENT OF ARTERIAL-HYPERTENSION [J].

FERRARA, LA ;

FASANO, ML ;

SORO, S ;

RUBBA, P ;

IANNUZZI, A .

JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 25 (03) :187-192

[97] METABOLIC ASPECTS OF ANTIHYPERTENSIVE TREATMENT WITH KETANSERIN [J].

FERRARA, LA ;

FASANO, ML ;

SORO, S .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (05) :1007-1008

[98]

FERRARA LA, 1985, J CARDIOVASC PHARM, V7, pS159

[99] ANTIHYPERTENSIVE EFFICACY OF THE COMBINATION OF KETANSERIN + THIAZIDE IN HYPERTENSIVES OLDER THAN 50 YEARS [J].

FERRARA, LA ;

FASANO, ML ;

SORO, S ;

PASANISI, F ;

MANCINI, M .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 :S124-S126

[100]

FINKIELMAN S, 1985, MEDICINA-BUENOS AIRE, V45, P447

← 5 6 7 8 9 10 11 12 13 14 →